Claims Study Shows Better Glycemic Control, Less Switching With Canagliflozin Than Dapagliflozin | Latest News RSS feed

Claims Study Shows Better Glycemic Control, Less Switching With Canagliflozin Than Dapagliflozin - Latest News


Lexicon Pharmaceuticals' CEO Hosts 2013 Research and Development Day Conference (Transcript)

Also if you look at the amount of urinary glucose excretion, this is someone less than that’s been higher doses of canagliflozin ... end of the study both the lower and the higher dose of LX4211 are a... read more

The Truth about Jardiance’s CV Risk Reduction

The study was initiated on September 2010 and concluded in April 2013. Background glucose-lowering therapy was unchanged for the first 12 weeks after randomization. After 12 weeks, adjustments were al... read more

Dr. Ralph DeFronzo

He received his medical degree from Harvard Medical School and has been in practice for more than 20 years. Dr. DeFronzo accepts several types of health insurance, listed below. He is one of 8 doctors ... read more

Looking for another news?


The Triple Aim: Care, Health, And Cost

Improving the U.S. health care system requires simultaneous pursuit of three aims: improving the experience of care, improving the health of populations, and reducing per capita costs of health care. ... read more


Zafgen, Inc. (ZFGN)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒ Indicate by check mark if the registrant is not required to file repo... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us